Search results
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 6 days agoBut AbbVie stock tumbled. Humira remains AbbVie's biggest moneymaker despite facing competition from...
Hundreds participate in ‘Walk to Cure Arthritis’ to help find a cure
WJXT Jacksonville· 6 days agoHundreds of people walked together Saturday at the Jacksonville Arboretum and Botanical Gardens to...
Shea Butter Is Your Secret Weapon For Lasting Moisture
PopSugar· 2 days agoMoisturizing your skin can feel like an endless task and trying to find the proper products with the...
Ashley Judd on the New White House Plan to Prevent Suicide
The Oprah Magazine via Yahoo News· 3 days agoThat understanding informs our feelings, and how we feel about someone creates how we treat them....
The Science of Glowing Skin—Experts Share How to Get a Luminous Complexion
Prevention· 1 day agoImagine for a moment what the human body would be like without skin (we know—ick—but bear with us):...
Children With Chronic Skin Disorders Face Substantial Stigma
Medscape· 4 days agoHealthcare professionals should be aware of the possibility of stigmatization and bullying when...
Johnson & Johnson (NYSE:JNJ) Shares Purchased by Telemus Capital LLC
ETF DAILY NEWS· 5 days agoTelemus Capital LLC increased its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 4 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
Rome Sentinel· 4 days agoNEW YORK, April 29, 2024 /PRNewswire/ --
Brokerages Set Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Target Price at $26.56
ETF DAILY NEWS· 6 hours agoArcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the company ...